NASDAQ:CYTK – Knox Daily

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Cytokinetics Inc’s recently made public that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $0.37

Insiders Updates

In a filing, Cytokinetics Inc revealed its President & CEO Blum Robert I unloaded Company’s shares for reported $0.26 million

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

In a filing, Cytokinetics Inc revealed its President & CEO Blum Robert I unloaded Company’s shares for reported $0.26 million

Stock Earnings

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

Cytokinetics Inc’s filing revealed that its Director WENDELL WIERENGA acquired Company’s shares for reported $0.23 million on Oct 28 ’24.

Analysts Viewpoint

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cytokinetics Inc

Stock Earnings

Cytokinetics Inc’s recent filing unveils that its EVP Research & Development Malik Fady Ibraham unloaded Company’s shares for reported $0.4

Stock Earnings

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Tag: NASDAQ:CYTK